Gengwen Tian

发表

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system.

Daofeng Liu, M. Hensel, Amy N. Courtney, 2014, Cancer research.

IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy

B. Liu, Amy N. Courtney, L. Metelitsa, 2018, The Journal of Immunology.

Development of an Effective Cancer Vaccine Using Attenuated Salmonella and Type III Secretion System to Deliver Recombinant Tumor-Associated Antigens Running title : Bacterial genes enable design of effective cancer vaccine

Daofeng Liu, M. Hensel, Amy N. Courtney, 2014 .

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.

Daofeng Liu, Hao Liu, E. Yvon, 2014, Blood.

Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells.

Daofeng Liu, S. Asgharzadeh, Liping Song, 2013, Clinical immunology.

Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma

Julien Balzeau, Amy N. Courtney, L. Metelitsa, 2023, Journal for ImmunoTherapy of Cancer.

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.

Daofeng Liu, Q. Mo, Amy N. Courtney, 2016, The Journal of clinical investigation.

Title: Invariant NKT Cells with Chimeric Antigen Receptor Provide a Novel Platform for Safe and Effective Cancer Immunotherapy Short title: NKT-cell platform for cancer immunotherapy

Daofeng Liu, Hao Liu, E. Yvon, 2017 .

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Daniel K. Wells, Chenling A. Xu, Meena Subramaniam, 2023, Nature Medicine.

LEF1 drives a central memory program and supports antitumor activity of natural killer T cells.

J. Rosen, Julien Balzeau, Amy N. Courtney, 2022, Cancer immunology research.

Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy.

Amy N. Courtney, L. Metelitsa, Gengwen Tian, 2022, Blood.

Abstract IA09: Harnessing natural and engineered properties of NKT cells for cancer immunotherapy

Amy N. Courtney, G. Dotti, A. Heczey, 2019, Tackling the Tumor Microenvironment: Beyond T-cells.

Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.

Nisha Ghatwai, A. Montalbano, Amy N. Courtney, 2024, Nature medicine.